These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2400360)

  • 21. The role of sex steroids and sex hormone binding globulin in hirsutism and/or oligomenorrhoea in obese and normal weight women.
    Cunningham SK; Loughlin T; Culliton M; McKenna TJ
    Ir Med J; 1985 Aug; 78(8):208-12. PubMed ID: 4044203
    [No Abstract]   [Full Text] [Related]  

  • 22. Spironolactone in combination drug therapy for unresponsive hirsutism.
    Pittaway DE; Maxson WS; Wentz AC
    Fertil Steril; 1985 Jun; 43(6):878-82. PubMed ID: 3158552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical efficacy and safety of low-dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism.
    Dodin S; Faure N; Cédrin I; Méchain C; Turcot-Lemay L; Guy J; Lemay A
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):575-82. PubMed ID: 8548942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does obesity diminish the positive effect of oral contraceptive treatment on hyperandrogenism in women with polycystic ovarian syndrome?
    Cibula D; Hill M; Fanta M; Sindelka G; Zivny J
    Hum Reprod; 2001 May; 16(5):940-4. PubMed ID: 11331641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?
    Escobar-Morreale HF; Serrano-Gotarredona J; García-Robles R; Sancho J; Varela C
    Metabolism; 1997 Aug; 46(8):902-7. PubMed ID: 9258272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polycystic ovary syndrome: a review for dermatologists: Part I. Diagnosis and manifestations.
    Housman E; Reynolds RV
    J Am Acad Dermatol; 2014 Nov; 71(5):847.e1-847.e10; quiz 857-8. PubMed ID: 25437977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and hormonal effects of the combination gonadotrophin-releasing hormone agonist plus oral contraceptive pills containing ethinyl-oestradiol (EE) and cyproterone acetate (CPA) versus the EE-CPA pill alone on polycystic ovarian disease-related hyperandrogenisms.
    Acién P; Mauri M; Gutierrez M
    Hum Reprod; 1997 Mar; 12(3):423-9. PubMed ID: 9130733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of obesity on hormonal parameters in hirsute and nonhirsute women.
    Bernasconi D; Del Monte P; Meozzi M; Randazzo M; Marugo A; Badaracco B; Marugo M
    Metabolism; 1996 Jan; 45(1):72-5. PubMed ID: 8544780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Endocrine and ultrasound examination of hirsutism].
    Baron JJ
    Zentralbl Gynakol; 1991; 113(9):511-7. PubMed ID: 1833937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 17-Hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) and treatment with oral contraceptive pills in PCOS women without metabolic comorbidities.
    Maier PS; Mattiello SS; Lages L; Spritzer PM
    Gynecol Endocrinol; 2012 Aug; 28(8):606-10. PubMed ID: 22329763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Which methods are relevant today in the diagnosis of hirsutism and which normal values can be omitted?].
    Carol W
    Zentralbl Gynakol; 1989; 111(8):540-6. PubMed ID: 2741595
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome.
    Ezeh U; Huang A; Landay M; Azziz R
    J Womens Health (Larchmt); 2018 Jul; 27(7):892-902. PubMed ID: 29878857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of hirsutism with the pure antiandrogen flutamide.
    Cusan L; Dupont A; Bélanger A; Tremblay RR; Manhes G; Labrie F
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 1):462-9. PubMed ID: 2212145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a combination of ethinylestradiol and desogestrel in adolescents with oligomenorrhea and ovarian hyperandrogenism.
    Nappi C; Farace MJ; Leone F; Minutolo M; Tommaselli AP; Montemagno U
    Eur J Obstet Gynecol Reprod Biol; 1987 Jul; 25(3):209-19. PubMed ID: 2956138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hirsutism.
    Morris DV
    Clin Obstet Gynaecol; 1985 Sep; 12(3):649-74. PubMed ID: 3905161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic alternatives for the hirsute woman.
    Bassaw B; Maharaj R; Ali A; Roopnarinesingh S
    West Indian Med J; 1992 Mar; 41(1):12-4. PubMed ID: 1533080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
    Toscano V; Bianchi P; Balducci R; Guglielmi R; Mangiantini A; Lubrano C; Sciarra F
    Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone.
    Wild RA; Demers LM; Applebaum-Bowden D; Lenker R
    Contraception; 1991 Aug; 44(2):113-24. PubMed ID: 1893706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome.
    Bradbury RA; Lee P; Smith HC
    Aust N Z J Obstet Gynaecol; 2017 Oct; 57(5):552-557. PubMed ID: 28597496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.